Eliot is a member of our life sciences patent team working in the biotechnology sector.
His technical expertise encompasses:
Eliot has experience in drafting and prosecuting patent applications for local and international clients. He also has experience of both offensive and defensive opposition proceedings.
Eliot has a degree from Cambridge University in Natural Sciences, majoring in pharmacology. Following his undergraduate degree, Eliot spent two years researching the biochemistry of innate immune receptors, such as C-type lectins; first at the University of Oxford and then at Imperial College London.
For his doctoral research at UCL, Eliot used HIV-based viral vectors to express novel fusion proteins designed to release a key immunogenic peptide within antigen presenting cells. The intracellular location of release ensured that the peptide was presented in a tolorogenic fashion, thus reducing autoimmunity in mice.
Eliot joined Mewburn Ellis in 2011 qualifying as a Chartered Patent Attorney in 2016 and a European Patent Attorney in 2015.